维普中文期刊产品整合服务
意见 帮助
基本检索 作者索引 机构索引 期刊索引
  • 哲学宗教
  • 社会学
  • 政治法律
  • 军事
  • 经济管理
  • 文化科学
  • 语言文字
  • 文学
  • 艺术
  • 历史地理
  • 自然科学总论
  • 理学
  • 天文地球
  • 生物学
  • 医药卫生
  • 农业科学
  • 一般工业技术
  • 矿业工程
  • 石油与天然气工程
  • 冶金工程
  • 金属学及工艺
  • 机械工程
  • 兵器科学与技术
  • 动力工程及工程热...
  • 核科学技术
  • 电气工程
  • 电子电信
  • 自动化与计算机技术
  • 化学工程
  • 轻工技术与工程
  • 建筑科学
  • 水利工程
  • 交通运输工程
  • 航空宇航科学技术
  • 环境科学与工程
时间 1989 - 2010 学科选择学科
题名/关键词 模糊
与 题名/关键词 模糊
重新搜索 在结果中搜索
5580篇 您的检索式：期刊名="Aliment Pharmacol Ther"
选中 清除  导出 查看参考文献 查看引证文献 引用追踪 共279页 首页 上一页 第1页 下一页 末页 /279 跳转
    题名 作者 年代 出处 被引量
1Meta‐analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma显示文摘K. V. Menon A. R. Hakeem N. D. Heaton 2012Aliment Pharmacol Ther2012，，4：8
2Meta‐analysis: the impact of oral anti‐viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B显示文摘A. K. Singal H. Salameh Y.‐F. Kuo R. J. Fontana 2013Aliment Pharmacol Ther2013，，2：6
3Review article: the diagnosis of non‐alcoholic fatty liver disease – availability and accuracy of non‐invasive methods显示文摘D. Festi R. Schiumerini L. Marzi A. R. Di Biase D. Mandolesi L. Montrone E. Scaioli G. Bonato G. Marchesini‐Reggiani A. Colecchia 2012Aliment Pharmacol Ther2012，，4：6
4Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome显示文摘J. Matricon M. Meleine A. Gelot T. Piche M. Dapoigny E. Muller D. Ardid 2012Aliment Pharmacol Ther (pt)2012，，11：6
5Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease显示文摘J. L. Anderson R. J. Edney K. Whelan 2012Aliment Pharmacol Ther2012，，6：5
6Meta‐analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease显示文摘H. Yuhara C. Steinmaus D. Corley J. Koike M. Igarashi T. Suzuki T. Mine 2013Aliment Pharmacol Ther2013，，10：5
7Associations of chronic hepatitis C with metabolic and cardiac outcomes显示文摘Z. M. Younossi M. Stepanova F. Nader Z. Younossi E. Elsheikh 2013Aliment Pharmacol Ther2013，，6：4
8Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub‐clinical inflammation and the impact on clinical assessment of disease activity显示文摘J. W. Berrill J. T. Green K. Hood A. K. Campbell 2013Aliment Pharmacol Ther2013，，1：4
9Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin‐18 fragments显示文摘R. Kwok Y.‐K. Tse G. L.‐H. Wong Y. Ha A. U. Lee M. C. Ngu H. L.‐Y. Chan V. W.‐S. Wong 2014Aliment Pharmacol Ther2014，，3：4
10Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence‐based international guide显示文摘A. P. S. Hungin C. Mulligan B. Pot P. Whorwell L. Agréus P. Fracasso C. Lionis J. Mendive J.‐M. Philippart de Foy G. Rubin C. Winchester N. Wit 2013Aliment Pharmacol Ther2013，，8：4
11Systematic review: Asian patients with chronic hepatitis C infection显示文摘L. H. Nguyen M. H. Nguyen 2013Aliment Pharmacol Ther2013，，10：4
12Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome显示文摘M. B. O. Lowén E. A. Mayer M. Sj?berg K. Tillisch B. Naliboff J. Labus P. Lundberg M. Str?m M. Engstr?m S. A. Walter 2013Aliment Pharmacol Ther2013，，12：4
13Systematic review with meta‐analysis: non‐alcoholic steatohepatitis ‐ a case for personalised treatment based on pathogenic targets显示文摘Z. M. Younossi M. J. Reyes A. Mishra R. Mehta L. Henry 2014Aliment Pharmacol Ther2014，，1：4
14Meta‐analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia显示文摘E. Dahl L. L. Gluud N. Kimer A. Krag 2012Aliment Pharmacol Ther2012，，7：3
15Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months显示文摘P. Meyrat E. Safroneeva A. M. Schoepfer 2012Aliment Pharmacol Ther (pt)2012，，11：3
16Prognostic value of liver fibrosis and steatosis biomarkers in type‐2 diabetes and dyslipidaemia显示文摘H. Perazzo M. Munteanu Y. Ngo P. Lebray N. Seurat F. Rutka M. Couteau S. Jacqueminet P. Giral D. Monneret F. Imbert‐Bismut V. Ratziu A. Hartemann‐Huertier C. Housset T. Poynard 2014Aliment Pharmacol Ther2014，，9：3
17Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease显示文摘L. Fedchuk F. Nascimbeni R. Pais F. Charlotte C. Housset V. Ratziu 2014Aliment Pharmacol Ther2014，，10：3
18Randomised clinical trial: the effects of H elicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer显示文摘S.‐J. Cho I. J. Choi M.‐C. Kook H. Yoon S. Park C. G. Kim J. Y. Lee J. H. Lee K. W. Ryu Y.‐W. Kim 2013Aliment Pharmacol Ther2013，，5：3
19Failure of H elicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients显示文摘Y. H. Kwon J. Heo H. S. Lee C. M. Cho S. W. Jeon 2014Aliment Pharmacol Ther2014，，6：3
20Systematic review: the efficacy of herbal therapy in inflammatory bowel disease显示文摘S. C. Ng Y. T. Lam K. K. F. Tsoi F. K. L. Chan J. J. Y. Sung J. C. Y. Wu 2013Aliment Pharmacol Ther2013，，8：3
返回顶部 每页显示：
共279页 首页 上一页 第1页 下一页 末页 /279 跳转
goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费